title: A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas.
authors.forename: K
authors.initials: K
authors.lastname: Aoki
authors.forename: Y
authors.initials: Y
authors.lastname: Shimada
authors.forename: N
authors.initials: N
authors.lastname: Okazaki
authors.forename: H
authors.initials: H
authors.lastname: Tajiri
authors.forename: H
authors.initials: H
authors.lastname: Nose
authors.forename: S
authors.initials: S
authors.lastname: Okada
authors.forename: K
authors.initials: K
authors.lastname: Shirao
authors.forename: T
authors.initials: T
authors.lastname: Yokota
authors.forename: S
authors.initials: S
authors.lastname: Yoshida
authors.forename: D
authors.initials: D
authors.lastname: Saitoh
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D004341:Drug Evaluation; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: D015251:Epirubicin